Increased Fecal Neopterin Parallels Gastrointestinal Symptoms in COVID-19.
Clin Transl Gastroenterol
; 12(1): e00293, 2021 01 12.
Article
in English
| MEDLINE | ID: covidwho-1028690
ABSTRACT
INTRODUCTION:
Coronavirus disease (COVID-19) has spread from Wuhan, China, and become a worldwide pandemic. Most patients display respiratory symptoms but up to 50% report gastrointestinal symptoms. Neopterin is a surrogate marker for viral inflammation, and its production by macrophages is driven by interferon-γ.METHODS:
We measured fecal neopterin in 37 hospitalized COVID-19 patients not requiring intensive care measures and 22 healthy controls.RESULTS:
Fecal neopterin was elevated in stool samples from COVID-19 patients compared with that in samples from healthy controls. Especially, patients reporting gastrointestinal symptoms exhibited increased fecal neopterin values.DISCUSSION:
COVID-19 is associated with an inflammatory immune response in the gastrointestinal tract.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Neopterin
/
Feces
/
Gastrointestinal Diseases
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
Topics:
Long Covid
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
English
Journal:
Clin Transl Gastroenterol
Year:
2021
Document Type:
Article
Affiliation country:
Ctg.0000000000000293
Similar
MEDLINE
...
LILACS
LIS